Data / Partner portfolio / UN agencies' core resources / World Health Organization
Country and regional regulatory capacity strengthened
Published title: Country and regional regulatory capacity strengthened, and supply of quality-assured and safe health products improved, including through prequalification services
US$ millions unless stated. Haitian fiscal year, October to September. FY2026-27 began October 1, 2026.
Description
The Secretariat will support countries to: implement regulation through reliance and national regulatory authorities networks; support and strengthen the capacity of national regulatory systems to achieve maturity level 3 using the WHO global benchmarking tool as the standard to determine the maturity and performance of national regulatory authorities for designation as WHO-Listed Authorities, and through this process strengthen country and regional regulatory oversight; address gaps identified in regulatory capacity for quality-assured and safe health products; strengthen capacity of pharmaceutical sector in countries that manufacture products for low- and middle-income countries and/or local supply in low- and middle-income countries; reinforce access by establishing and improving local production and develop model strategies for quality-assured medicines and other health products; strengthen post-market surveillance
more
and pharmacovigilance of medical products to ensure access to quality, safe and efficacious health products in order to improve the detection of, the response to, and prevent use of substandard and falsified medical products; disseminate product alerts of substandard and falsified medical products; develop, adopt and strengthen national and regional regulatory preparedness, and use regulatory networks to facilitate regulatory procedures for risk-based and expedited (when needed) evaluations during public health emergencies; and strengthen capacity for production of medicines, vaccines and other health products. In producing technical products on norms/standard, data and research, the Secretariat will: strengthen and expand WHO prequalification lists, including the WHO model list of essential in vitro diagnostics; continue to develop processes and procedures for the prequalification of vector-control products; develop new pathways to prequalification listing and new risk-based approaches to support time-limited procurement; develop technical guidance to expand the scope of prequalification for all product streams and expand the range of products eligible for prequalification in order to ensure that the low- and middle-income country context is a driver of innovation and product development; develop relevant regulatory tools, guidelines and practices, as well as platforms and pathways, to facilitate the registration of medicines, vaccines and diagnostics through joint reviews and emergency use listing; and develop evidence-based capacity-buildingand technical assistance packages for promoting quality production of health products.
- Sector
- Health
- Stage
- Closed since December 31, 2025
- Approval
- January 1, 2024
- Closing
- December 31, 2025
- Disbursed as of
- Not reported
- Implementing agency
- Not reported
- Effectiveness
- Not reported
- Departments
- Ouest
- Last transaction
- January 1, 2024
- Operation ID
- core:IATI:XM-DAC-928-HT-2024-25-01.003.AM01.HTI03
Financing
Table 1.Position at the data date by source (stocks), US$ millions
| This page | Source | |
|---|---|---|
| Commitment | Not reported | |
| Disbursed | Not reported | |
| UndisbursedThe balance each partner reports as not yet disbursed, summed only when every operation in scope reports it. | Not reported | |
| Total cost | Not reported |
IATI amounts. Approved: The commitments the partner reports, converted to US$. Disbursed to date: The disbursements (IATI transaction type 3, funds paid to another organization) and expenditure (type 4, funds spent by the publisher) the partner reports, converted to US$. Undisbursed: The undisbursed balance the record gives, where the partner reports one, in US$. Amounts by source
Changes to the operationnot reported
- Original closing date
- Not reported
- Closing date extensions
- Not reported
- Restructurings
- Not reported
- Emergency component
- Not reported
New commitments and disbursements by fiscal year
Table 2.New commitments and disbursements by fiscal year (flows), US$ millions
| FY2023-24US$ millions | |
|---|---|
| New commitments | <0.1 |
| Disbursements | Not reported |
| Cumulative disbursements | Not reported |
Records and documents
Transactions1 transaction, January 1, 2024
Table 3.Transactions, US$ millions
| Date | Measure | AmountUS$ millions | Source | Method |
|---|---|---|---|---|
| January 1, 2024 | Commitment | <0.1 | IATI | incoming funds reported by the agency, provider as filed; country share applied |
Terms5 of 6 reported
- Finance type
- 110 Standard grant
- Flow type
- 10 Official development assistance
- Aid type
- B03 Contributions to specific-purpose programs and funds managed by implementing partners
- Tied status
- 5 Untied
- Collaboration type
- 4 Multilateral outflows
- Humanitarian
- Not reported
Locations1 department
| Departments | Ouest |
| Places named by the source | Not reported |
| Places with coordinates | 0 |
Partner documents
No document is listed for this operation.
Sources
- IATI record (d-portal): terms of use set by the publisher
Data as of October 21, 2026
| Source | Accessed on |
|---|---|
| IATI | October 21, 2026 |
Cite this page
HaitiDocs. Country and regional regulatory capacity strengthened. Partner portfolio, data as of October 21, 2026. https://www.haitidocs.org/portfolio/projects/UNFUND%3Acore%3AIATI%3AXM-DAC-928-HT-2024-25-01.003.AM01.HTI03